HLA-DOA


Summary: HLA-DOA belongs to the HLA class II alpha chain paralogues. HLA-DOA forms a heterodimer with HLA-DOB. The heterodimer, HLA-DO, is found in lysosomes in B cells and regulates HLA-DM-mediated peptide loading on MHC class II molecules. In comparison with classical HLA class II molecules, this gene exhibits very little sequence variation, especially at the protein level. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in HLA-DOA


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC TAS GO:0005765 lysosomal membrane
CC TAS GO:0005886 plasma membrane
CC IEA GO:0010008 endosome membrane
CC IEA GO:0016021 integral component of membrane
CC IDA GO:0042613 MHC class II protein complex
BP IDA GO:0002587 negative regulation of antigen processing and presentation of peptide antigen via MHC class II
Showing 1 to 6 of 13 rows rows per page

Gene expression in normal tissue: HLA-DOA

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

ERK MAPK signaling1

Pathways in HLA-DOA


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP2328 Allograft Rejection
kegg hsa04145 Phagosome - Homo sapiens (human)
kegg hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human)
kegg hsa04612 Antigen processing and presentation - Homo sapiens (human)
kegg hsa04640 Hematopoietic cell lineage - Homo sapiens (human)
kegg hsa04658 Th1 and Th2 cell differentiation - Homo sapiens (human)
Showing 1 to 6 of 27 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HLA-DOA

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​